Great new work from #TRACERx team: Subclonal immune evasion in non-small cell lung cancer!

First study ex vivo #NSCLC demonstrating #PDOs are an excellent technology on #subclonal tumor evolution affecting #immuneescape.

t.co/1YUzihcY2H

#nonanimal #alternative #methods #cancer #immunotherapy